Related Experiment Video
Updated: Sep 3, 2025

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.2K
Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In
Paul A Valle1, Raul Garrido1, Yolocuauhtli Salazar2
1Postgraduate Program in Engineering Sciences, BioMath Research Group, Tecnológico Nacional de México/IT Tijuana, Blvd. Alberto Limón Padilla s/n, Tijuana 22454, Mexico.
Pharmaceutics
|July 27, 2022
Summary
This study models chronic lymphocytic leukemia treatment using CAR-T cells and chlorambucil. Mathematical conditions were derived for leukemia eradication and cell persistence, guiding therapy design for improved outcomes.
Area of Science:
- Mathematical Oncology
- Immunotherapy
- Pharmacology
Background:
- Cancer, including leukemia, remains a significant global health challenge with complex evolution and survival mechanisms.
- Existing treatments face limitations due to cancer's adaptability, necessitating advanced therapeutic strategies.
Purpose of the Study:
- To model chronic lymphocytic leukemia (CLL) growth dynamics under combined CAR-T cell and chlorambucil treatment.
- To establish mathematical conditions for leukemia cell eradication and persistence of CAR-T and cancer cells.
Main Methods:
- Utilized nonlinear dynamical systems and first-order Ordinary Differential Equations to represent cancer growth.
- Applied nonlinear theories to derive conditions for cell eradication and persistence.
- Conducted in silico experiments and numerical simulations to validate findings and design protocols.
Main Results:
- Sufficient conditions for leukemia cell eradication were established.
- Necessary conditions for the long-term persistence of CAR-T and leukemia cells were identified, crucial for treatment dosing.
- Therapy administration protocols were designed for complete leukemia eradication using CAR-T cells and chemoimmunotherapy.
Conclusions:
- The study provides a mathematical framework for understanding and optimizing CLL treatment.
- Derived conditions offer critical insights for designing effective therapeutic strategies, including dose thresholds for cytotoxic effects.
- Formulated equations estimate the cytotoxicity of chlorambucil and CAR-T cells, with validated parameters.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652

